Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 1;24(4):349-353.
doi: 10.1097/MCO.0000000000000762.

Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction

Renata Risi  1 , Rossella Tozzi  2 , Mikiko Watanabe  1
Affiliations
Review

Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction

Renata Risi et al. Curr Opin Clin Nutr Metab Care. .

Abstract

Purpose of review: The low fat diet (LFD) is currently the first choice to treat nonalcoholic fatty liver disease (NAFLD) alongside with physical activity. However, low carbohydrate diets (LCDs) and ketogenic diets have gained attention lately, thanks to their favourable impact in reducing intrahepatic triglyceride content. We therefore aimed at providing an update on recent evidence evaluating the hepatoprotective effects of such dietary interventions.

Recent findings: Novel findings confirmed previous evidence by showing beneficial effects on liver fat content reduction for both LFDs and LCDs. The further restriction of carbohydrates to less than 50 g/day, usually leading to ketosis, confirmed to produce an improvement in NAFLD, with very low-calorie ketogenic diets possibly proving particularly beneficial thanks to the significant weight loss that can be obtained.

Summary: Most of the latest evidence shows that carbohydrate restriction plays a fundamental role in the modulation of lipid metabolism leading to similar efficacy in improving NAFLD compared with LFDs. The hepatoprotective role of carbohydrate restriction appears to be boosted when ketogenesis is induced, when the total calorie intake is extremely reduced, or, possibly, when dietary interventions have reduced content in free sugars, making such interventions valuable tools to deal with NAFLD.

PubMed Disclaimer

References

    1. Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism 2019; 92:82–97.
    1. Watanabe M, Risi R, De Giorgi F, et al. Obesity treatment within the Italian national healthcare system tertiary care centers: what can we learn? Eat Weight Disord 2020; 26:771–778.
    1. Leoni S, Tovoli F, Napoli L, et al. Current guidelines for the management of nonalcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol 2018; 24:3361–3373.
    1. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015; 149:367–378. e365; quiz e314–365.
    1. Watanabe M, Tozzi R, Risi R, et al. Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: a comprehensive review of the literature. Obes Rev 2020; 21:e13024.

Publication types

MeSH terms

Substances